Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease. Issue 10 (18th September 2020) - Osterman, Mark T; Gordon, Ilyssa O; Davis, Elisabeth M; Ciorba, Matthew; Glover, Sarah C; Abraham, Bincy; Khan, Freeha; Guo, Xueyan; Yee, Eric U; Allard, Felicia D; Claggett, Brian; Shen, Bo; et al.